Some people can’t get their bad cholesterol levels down, even if they take cholesterol-lowering meds. A new clinical trial ...

(Reuters) -A federal jury in Delaware said on Thursday that biotech company Amgen owes competitor Regeneron more than $406 ...

An international study led by Monash University has found that a new cholesterol-lowering drug called Obicetrapib could offer ...

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win over its rival. | A federal jury in Delaware has ...

Natural statins are dietary supplements known for their ability to lower cholesterol. Certain foods contain natural ...

This superfood is crafted from a unique yeast that has a compound similar to that found in statin medications.

Researchers have discovered a promising new drug combination that significantly lowers “bad” LDL cholesterol for people whose ...

A new drug combo lowers "bad" LDL cholesterol for people whose levels remain high even after taking statins. The new pill ...

A Monash-led international study has found a cholesterol-lowering drug may offer a more effective and convenient way to protect people at high risk of heart attack and stroke. The clinical trial ...

A recent trial found a new drug may help lower bad cholesterol levels in people when statins alone are not enough.

The jury agreed with Regeneron, opens new tab that Amgen unlawfully bundled Repatha with two of its blockbuster anti-inflammatory drugs to persuade pharmacy benefit managers to buy it instead of ...